Vijay K. Vanguri - Concepedia

Author

Vijay K. Vanguri

University of Massachusetts Chan Medical School ORCID

Also Known As

V. K. Vanguri, V. Vanguri, V.K. Vanguri, Vijay K Vanguri, Vijay K. VANGURI, Vijay K. Vanguri, Vijay Vanguri

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

University of Massachusetts Chan Medical School Harvard University Brigham and Women's Hospital Dana-Farber Cancer Institute Juntendo University

About

Vijay K. Vanguri is an author at University of Massachusetts Chan Medical School specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	650
2	Cell Biology	5	5	446
3	Engineering	1	1	45
4	Cellular Therapies	1	1	66
5	Computer Engineering	1	1	45

Vijay K. Vanguri

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells Loise M. Francisco, Victor H. Salinas, Keturah Brown, The Journal of Experimental Medicine	2009	2K
The Programmed Death-1 Ligand 1:B7-1 Pathway Restrains Diabetogenic Effector T Cells In Vivo Alison M. Paterson, Keturah Brown, Mary Keir, The Journal of Immunology T-regulatory CellApoptosisImmunologyCell DeathImmunologic Mechanism	2011	203
PD-L1 has distinct functions in hematopoietic and nonhematopoietic cells in regulating T cell responses during chronic infection in mice Scott N. Mueller, Vijay K. Vanguri, Sang‐Jun Ha, Journal of Clinical Investigation Adaptive Immune SystemT-regulatory CellViral ImmunityImmunologyPathology	2010	153
The Novel Costimulatory Programmed Death Ligand 1/B7.1 Pathway Is Functional in Inhibiting Alloimmune Responses In Vivo Yang Jun, Leonardo V. Riella, Susanne Chock, The Journal of Immunology	2011	132
Relapsing–Remitting Central Nervous System Autoimmunity Mediated by GFAP-Specific CD8 T Cells Katsuhiro Sasaki, Angela Bean, Shivanee Shah, The Journal of Immunology	2014	112
Critical Role of Donor Tissue Expression of Programmed Death Ligand-1 in Regulating Cardiac Allograft Rejection and Vasculopathy Jun Yang, Joyce Popoola, Shakila Khandwala, Circulation	2008	94
A novel murine infection model for Shiga toxin–producing Escherichia coli Emily M. Mallick, Megan E. McBee, Vijay K. Vanguri, Journal of Clinical Investigation	2012	89
Solitary Fibrous Tumor of the Oral Cavity: Clinicopathologic and Immunohistochemical Study of 21 Cases Esther O’Regan, Vijay K. Vanguri, Carl M. Allen, Head and Neck Pathology Immunohistochemical StudySolitary Fibrous TumorOral CavitySurgical PathologyPathology	2009	82
Essential Role of PDL1 Expression on Nonhematopoietic Donor Cells in Acquired Tolerance to Vascularized Cardiac Allografts Leonardo V. Riella, Toshihiko Watanabe, Peter T. Sage, American Journal of Transplantation Cell TherapyTransplantationEssential RoleAcquired ToleranceImmunology	2011	66
SnapShot: B7/CD28 Costimulation Alison M. Paterson, Vijay K. Vanguri, Arlene H. Sharpe Cell High Performance ComputingCluster ComputingEngineeringB7/cd28 CostimulationAdvanced Computing	2009	45

Page 1